Neuroimmunology Drugs Market Key Players Analysis - AB Science SA (France), Actelion Pharmaceuticals Ltd. (Switzerland), AstronauTx (UK), AZTherapies Inc. (US), Biogen Inc. (US)

Neuroimmunology Drugs Market to Record An Exponential CAGR By 2030.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on "Neuroimmunology Drugs Market- By Trends, Industry Competition Analysis, Revenue and Forecast to 2030."

Get Free Access to Demo Report, Excel Pivot and ToC :https://www.insightaceanalytic.com/request-sample/1171

Neuroimmunology is the study of how the central nervous system interacts with the body's immune system. Scientists investigate these interactions during development, homeostasis, and injury response with the primary goal of discovering treatments or prevention for neuroimmunological disorders.
Factors such as the growing cases of neuroimmunological diseases, rising aging population, advancements in neurogenetics, increasing R&D activities among research institutes and pharmaceutical companies to innovate new treatment options for neurological disorders, surging patient preference toward cost-effective drug treatments, and the availability of strong candidates to treat multiple sclerosis and Alzheimer's disease in clinical development are expected to drive the market in the future.
In 2019, over 400,000 Americans and 2.5 million people worldwide were diagnosed with multiple sclerosis. As a result, the increasing prevalence of neuroimmunology illnesses is expected to drive up demand for neuroimmunology medications during the predicted period.
However, the high cost of these medications is expected to limit market growth over the projection period.

Geographically, North America is expected to have the largest market share over the forecast period (2020-2030), followed by Europe, due to the rising prevalence of neuroimmunology diseases, the presence of important industry players, and increased awareness about mental health. Furthermore, Asia-Pacific is expected to lead the market in the approaching years due to the availability of well-developed healthcare facilities and increased government funding for neurology research.

Expert Knowledge, Just a Click Away:https://calendly.com/insightaceanalytic/30min?month=2024-02

Major market players operating in the neuroimmunology drugs market include AB Science SA (France), Actelion Pharmaceuticals Ltd. (Switzerland), AstronauTx (UK), AZTherapies Inc. (US), Biogen Inc. (US), Celgene Corp. (US), INmune Bio, Inc. (US), Lundbeck (Denmark), F. Hoffmann-La Roche AG (Switzerland), Genetech Inc. (US), Grifols SA (Spain), Tiaki Therapeutics (US), TG Therapeutics Inc. (US), and TauRX Therapeutics Ltd (UK) among others.

Some of the key developments in the market:
• In June 2021, Biogen (US) and Eisai Inc. (Japan) started steps to improve ADUHELM medicine access for all Alzheimer's patients. The FDA authorized ADUHELM as the first and only Alzheimer's disease medication to address a disease-defining pathology by lowering amyloid-beta plaques in the brain. These initiatives assist patients and their families in understanding the disease, navigating the diagnostic process, receiving culturally competent care, and affording treatment.
• In June 2021, the European Commission authorized Roche's ENSPRYNG (satralizumab) as the first at-home subcutaneous treatment for neuromyelitis optica spectrum disease (NMOSD).
• In August 2019, AstronauTx got a USD 6.5 million funding from the government-launched Dementia Discovery Fund (DDF) to discover drugs that reset the behavior of astrocytes, which are important support cells in the brain (dementia research).

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1171

Market Segments
Neuroimmunology Drugs Market, by Indication, 2020-2030 (Value US$ Mn)
• Alzheimer's disease (AD)
• Multiple Sclerosis (MS)
• Others
Neuroimmunology Drugs Market, by Target Type, 2020-2030 (Value US$ Mn)
• Cytokines
• Lymphocytes or Molecules Associated with their Activation or Migration
• Others
Neuroimmunology Drugs Market, by Region, 2020-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Neuroimmunology Drugs Market, by Country, 2020-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Neuroimmunology Drugs Market, by Country, 2020-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Neuroimmunology Drugs Market, by Country, 2020-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Neuroimmunology Drugs Market, by Country, 2020-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Neuroimmunology Drugs Market, by Country, 2020-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Empower Your Decision-Making with 180 Pages Full Report @https://www.insightaceanalytic.com/buy-report/1171

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.